For Amgen and Novartis, investing in the latest fund from Atlas Venture wasn't enough. The Cambridge, MA-based venture firm has struck separate agreements with the two major drugmakers to join forces…
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!by Richard Daverman, PhDMay 15, 2013 -- Last week, Amgen and Zhejiang Beta Pharma announced they would form a…
Amgen and Zhejiang Beta Pharma have signed an agreement to form a joint venture (JV) to commercialize Amgen's Vectibix (panitumumab) in the Chinese market.
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!Amgen and Zhejiang Beta Pharma Announce Planned Joint Venture in ChinaTHOUSAND OAKS, Calif. and ZHEJIANG, Chi…
